Omar Oakes
May 8, 2018

GSK reviews global media

Pharma giant GlaxoSmithKline has reportedly launched a review of its US $1.8 billion global media agency arrangements, putting MediaCom and PHD on alert.

GSK reviews global media

The review, which is being handled by ID Comms, comes less than three years after GSK awarded its European business to MediaCom, while PHD was handed its US media account.

Both agencies had retained the accounts in 2015 following a global media review, after having been first appointed in 2013.

A year later, GSK completed an agency review for the other parts of its marketing comms business by hiring nine agencies, including Grey and Saatchi & Saatchi for advertising.

GSK's agencies were appointed to work on the company's seven power brands (Sensodyne, Parodontax, Poligrip, Voltaren, Panadol, Theraflu and Otrivin) and 12 core brands (Biotene, Contac, Flonase, Excedrin, Fenbid, Tums, ENO, Horlicks, Physiogel, Lamisil, Fenistil and Abreva/Zovirax).

GSK did not respond to a request for comment by Campaign UK by press time while MediaCom and PHD would not comment and referred Campaign to GSK.

Source:
Campaign UK

Related Articles

Just Published

2 days ago

Asia-Pacific Power List 2024: Robin Liu, Miniso

Through strategic co-branding and localisation, Liu is steering Miniso towards global super-brand status with innovative marketing strategies and leveraging relevant IP.

2 days ago

Creative Minds: Koji Kanzaki on turning childhood ...

From aspiring comedian to comic fan and now creative director, Dentsu China’s ECD Koji Kanzaki loves uncovering beauty in the mundane, dreams of dining with Banksy, and keeps his inner child alive.

2 days ago

Wieden+Kennedy retreats from India, shuttering its ...

The agency's leadership in India including Ayesha Ghosh, Santosh Padhi and Shreekant Srinivasan have resigned.

2 days ago

Exit player zero: A creative director’s brush with ...

When a dream role at a gaming startup pulled in Robert Gaxiola, the veteran creative director and Playbook XP managing partner, quickly realised the cost to play was far too steep. Now, he’s urging fellow creatives to be wary of the same traps.